You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metronomic vinorelbine

Showing 1 - 25 of 477
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Xi'an (metronomic oral vinorelbine plus anlotinib)

Recruiting
  • Breast Cancer
  • metronomic oral vinorelbine plus anlotinib
  • Xi'an, Shaanxi, China
    Xi'an International Medical Center Hospital
Aug 27, 2023

EGFR, NSCLC, Third-generation TKI Trial (Almonertinib and metronomic oral vinorelbine)

Not yet recruiting
  • EGFR
  • +2 more
  • Almonertinib and metronomic oral vinorelbine
  • (no location specified)
Dec 21, 2022

Metastatic Breast Cancer Trial in Beijing (Vinorelbine 40mg, Toripalimab 240mg, Bevacizumab 5 mg/kg)

Recruiting
  • Metastatic Breast Cancer
  • Vinorelbine 40mg
  • +5 more
  • Beijing, Beijing, China
  • +1 more
Feb 9, 2022

Breast Cancer Trial in Beijing (oral vinorelbine and capecitabine)

Recruiting
  • Breast Cancer
  • oral vinorelbine and capecitabine
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Feb 27, 2023

Advanced Solid Tumours, Breast Cancer, Head Neck Cancer Trial in France (Durvalumab + Tremelimumab + metronomic Vinorelbine)

Active, not recruiting
  • Advanced Solid Tumours
  • +4 more
  • Durvalumab + Tremelimumab + metronomic Vinorelbine
  • Angers, France
  • +8 more
Jun 1, 2022

Non Small Cell Lung Cancer (NSCLC), Malignant Pleural Mesothelioma (MPM) Trial in Marseille (Vinorelbine)

Completed
  • Non Small Cell Lung Cancer (NSCLC)
  • Malignant Pleural Mesothelioma (MPM)
  • Marseille, France
    Assistance Publique des Hôpitaux de Marseille (CEPCM)
Nov 15, 2022

NSCLC, Carcinoma Breast Trial in Suzhou (Vinorelbine, Radiotherapy, PD-1/PD-L1 inhibitor)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma Breast
  • Suzhou, China
    Second Affiliated Hospital of Soochow University
Oct 29, 2022

NSCLC Trial in France (Atezolizumab, Vinorelbine)

Completed
  • Non-small Cell Lung Cancer
  • Aix-en-Provence, France
  • +12 more
May 11, 2022

Breast Cancer Trial in Italy (Paclitaxel, Cyclophosphamide, Capecitabine)

Active, not recruiting
  • Breast Cancer
  • Aviano, Italy
  • +19 more
Aug 31, 2022

Breast Cancer Trial in Besançon (Letrozole, Anastrozole, Vinorelbine)

Terminated
  • Breast Cancer
  • Besançon, France
    CHU Besançon
Jan 29, 2021

Aggressive Non-Hodgkin Lymphoma Trial in Italy (Prednisone, Vinorelbine, Etoposide)

Completed
  • Aggressive Non-Hodgkin Lymphoma
  • Brescia, Italy
  • +9 more
Dec 17, 2021

Advanced Breast Cancer Trial in Milan (Vinorelbine, Capecitabine, Cyclophosphamide)

Unknown status
  • Advanced Breast Cancer
  • Milan, Italy
    European Institute of Oncology
Apr 24, 2020

Metronomic Oral Vinorelbine in Elderly Locally Advanced /

Unknown status
  • Locally Advanced/ Metastatic NSCLC
  • Pesaro, Yes, Italy
    Azienda Ospedaliera Ospedali Riuniti Marche Nord
Dec 23, 2019

Lung Tumor Malignant Trial in Guangzhou (Vinorelbine Oral)

Terminated
  • Lung Neoplasm Malignant
  • Vinorelbine Oral
  • Guangzhou, Guangdong, China
    Guangdong General Hospital
Mar 10, 2020

Lung Cancer Trial in Spain (Vinorelbine, Cisplatin, Radiotherapy)

Completed
  • Lung Cancer
  • Elche, Alicante, Spain
  • +17 more
Jan 8, 2020

Metastatic Breast Cancer Trial in Germany (Vinorelbine)

Completed
  • Metastatic Breast Cancer
  • Dusseldorf, Germany
  • +7 more
Aug 9, 2019

Non Small Cell Lung Cancer Trial in United States (Viagenpumatucel-L, Metronomic Cyclophosphamide, Physician's Choice Regimen

Terminated
Has Results
  • Non Small Cell Lung Cancer
  • Rogers, Arkansas
  • +15 more
Jan 24, 2020

Breast Cancer, Chemo Effect Trial in Beijing (Chidamide)

Recruiting
  • Breast Cancer
  • Chemotherapy Effect
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Feb 17, 2023

Gastric Cancer Trial in Shanghai (sintilimab+metronomic PLOF)

Recruiting
  • Gastric Cancer
  • sintilimab+metronomic PLOF
  • Shanghai, China
    Huashan Hospital, Fudan University
Sep 22, 2023

Breast Cancer Trial in Spain (Oral Vinorelbine, Letrozole)

Completed
  • Breast Cancer
  • Barcelona, Spain
  • +9 more
Sep 18, 2018

Breast Carcinoma, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Chicago

Not yet recruiting
  • Breast Carcinoma
  • +2 more
  • Biospecimen Collection
  • +6 more
  • Chicago, Illinois
    Northwestern University
Nov 14, 2023

Breast Cancer Trial in Chicago (Cyclophosphamide, Methotrexate, Capecitabine)

Recruiting
  • Breast Cancer
  • Chicago, Illinois
    University of Illinois
Oct 18, 2023

to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally

Recruiting
  • to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma
  • Capecitabine 500Mg Oral Tablet
  • Shanghai, China
    Eye & ENT Hospital, Fudan University
Jul 2, 2023

Colo-rectal Cancer, Metastatic Cancer Trial in Besançon, Dijon, Montbéliard (Regorafenib, Cyclophosphamide, Capecitabine)

Active, not recruiting
  • Colo-rectal Cancer
  • Metastatic Cancer
  • Besançon, France
  • +2 more
Jan 24, 2023

Breast Cancer Trial in Nanjing (Inetetamab, Pyrotinib, Oral Vinorelbine Tartrate)

Recruiting
  • Breast Cancer
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Apr 10, 2023